These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15971465)

  • 1. What is the best marker for inhaled corticosteroid safety?
    Derendorf H; Hochhaus G
    Allergy Asthma Proc; 2005; 26(2):89-93. PubMed ID: 15971465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.
    Meibohm B; Hochhaus G; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
    J Pharmacokinet Biopharm; 1999 Apr; 27(2):127-47. PubMed ID: 10567952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled corticosteroids: clinical relevance of safety measures.
    Price JF
    Pediatr Pulmonol Suppl; 1997 Sep; 15():40-5. PubMed ID: 9316101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review.
    Wlodarczyk JH; Gibson PG; Caeser M
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):23-30. PubMed ID: 18254478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic side effects of inhaled corticosteroids in patients with asthma.
    Dahl R
    Respir Med; 2006 Aug; 100(8):1307-17. PubMed ID: 16412623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
    Wu K; Goyal N; Stark JG; Hochhaus G
    J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of inhaled corticosteroid therapy in young children with asthma.
    Turktas I; Ozkaya O; Bostanci I; Bideci A; Cinaz P
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):649-54. PubMed ID: 11428737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled steroids for children: effects on growth, bone, and adrenal function.
    Allen DB
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):555-64, viii. PubMed ID: 16085159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone.
    Wilson AM; Sims EJ; Struthers AD; Lipworth BJ
    Clin Sci (Lond); 1998 Oct; 95(4):513-7. PubMed ID: 9748428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of inhaled corticosteroids in asthma.
    Jackson LD; Polygenis D; McIvor RA; Worthington I
    Can J Clin Pharmacol; 1999; 6(1):26-37. PubMed ID: 10465863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism.
    Derendorf H; Hochhaus G; Krishnaswami S; Meibohm B; Möllmann H
    Pharmazie; 2000 Mar; 55(3):223-7. PubMed ID: 10756545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol suppression as a surrogate marker for inhaled corticosteroid-induced growth retardation in children.
    Xu J; Sabarinath SN; Derendorf H
    Eur J Pharm Sci; 2009 Jan; 36(1):110-21. PubMed ID: 19028577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device.
    Goldberg S; Algur N; Levi M; Brukheimer E; Hirsch HJ; Branski D; Kerem E
    Ann Allergy Asthma Immunol; 1996 Mar; 76(3):234-8. PubMed ID: 8634875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation.
    Fink RS; Pierre LN; Daley-Yates PT; Richards DH; Gibson A; Honour JW
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4541-6. PubMed ID: 12364432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature.
    Schwartz RH; Neacsu O; Ascher DP; Alpan O
    Clin Pediatr (Phila); 2012 Dec; 51(12):1184-90. PubMed ID: 23043135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral health in patients on inhaled corticosteroid treatment.
    Komerik N; Akkaya A; Yildiz M; Buyukkaplan US; Kuru L
    Oral Dis; 2005 Sep; 11(5):303-8. PubMed ID: 16120117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids.
    Meibohm B; Derendorf H; Möllmann H; Fröhlich P; Tromm A; Wagner M; Homrighausen S; Krieg M; Hochhaus G
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):367-76. PubMed ID: 10475139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary cortisol levels in prepubertal children using inhaled corticosteroids with or without concurrent intranasal corticosteroids.
    Heijsman SM; de Vries TW; Wolthuis A; Kamps AW
    Pediatr Pulmonol; 2011 Nov; 46(11):1055-61. PubMed ID: 21520445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma.
    White M; Crisalida T; Li H; Economides A; Kaliner M
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):437-44. PubMed ID: 16597078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.